 |
인쇄하기
취소
|
Janssen Korea to take legal actions over Ultracet
Janssen Korea has pledged to take legal action against the nullification trial of Ultracet, a painkiller for the relief of moderate to severe pain, which has been raised by several Korean drug makers including Hanmi Pharm, a senior official said on November 13.
The detailed legal action will be made public within one to two weeks trough our proxy, he added.
Compared to nonsteroidal anti-i...
The detailed legal action will be made public within one to two weeks trough our proxy, he added.
Compared to nonsteroidal anti-i...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.